Although TACE inhibitors are efficient in protecting against lipopolysaccharide/d-(+)-galactosamine-induced lethal hepatitis by inhibition of TNF-α release, inhibition of TACE by BB-94 was deemed irrelevant in their model; however, data was not shown [28]. Here, ADAM17 is linked to hepatitis A virus infection.